| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |